Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer
Not yet recruiting · NCT07528430 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Not yet recruiting | Not stated | 2026-07-29 | NCT07528430 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| EPOCH Epigenetics, Inc | 3 |
| University of Maryland, Baltimore | 198 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Maryland Baltimore Washington Medical Center | Glen Burnie | United States | 4 |